MX2019007485A - Preparacion oftalmologica. - Google Patents

Preparacion oftalmologica.

Info

Publication number
MX2019007485A
MX2019007485A MX2019007485A MX2019007485A MX2019007485A MX 2019007485 A MX2019007485 A MX 2019007485A MX 2019007485 A MX2019007485 A MX 2019007485A MX 2019007485 A MX2019007485 A MX 2019007485A MX 2019007485 A MX2019007485 A MX 2019007485A
Authority
MX
Mexico
Prior art keywords
preparation
ophthalmologic
water soluble
ophtalmologic
fibrous carrier
Prior art date
Application number
MX2019007485A
Other languages
English (en)
Inventor
Knotkova Katerina
Kotzianova Adela
Velebny Vladimir
Original Assignee
Contipro As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Contipro As filed Critical Contipro As
Publication of MX2019007485A publication Critical patent/MX2019007485A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A61K9/0051—Ocular inserts, ocular implants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0092—Hollow drug-filled fibres, tubes of the core-shell type, coated fibres, coated rods, microtubules or nanotubes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nanotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invención describe la preparación oftalmológica especialmente para el tratamiento y prevención de enfermedades y trastornos oftalmológicos. Esta preparación oftalmológica está en forma del portador fibroso sólido que comprende fibras solubles en agua que contienen ácido hialurónico o su sal farmacéuticamente aceptable y/o un derivado del mismo y además contiene el polímero sintético soluble en agua y el agente activo, el portador fibroso sólido se disuelve al contacto con el ojo.
MX2019007485A 2016-12-23 2017-12-22 Preparacion oftalmologica. MX2019007485A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CZ2016-827A CZ2016827A3 (cs) 2016-12-23 2016-12-23 Oftalmologický prostředek
PCT/CZ2017/050066 WO2018113805A1 (en) 2016-12-23 2017-12-22 Ophtalmologic preparation

Publications (1)

Publication Number Publication Date
MX2019007485A true MX2019007485A (es) 2019-08-29

Family

ID=61070241

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2019007485A MX2019007485A (es) 2016-12-23 2017-12-22 Preparacion oftalmologica.

Country Status (8)

Country Link
EP (1) EP3558264B1 (es)
KR (1) KR102511776B1 (es)
AR (1) AR110433A1 (es)
BR (1) BR112019012758A2 (es)
CZ (1) CZ2016827A3 (es)
JO (1) JOP20190137A1 (es)
MX (1) MX2019007485A (es)
WO (1) WO2018113805A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ202132A3 (cs) * 2021-01-26 2022-04-20 Contipro A.S. Prostředek pro hojení ran, způsob jeho výroby a použití

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4851521A (en) * 1985-07-08 1989-07-25 Fidia, S.P.A. Esters of hyaluronic acid
JP2855307B2 (ja) * 1992-02-05 1999-02-10 生化学工業株式会社 光反応性グリコサミノグリカン、架橋グリコサミノグリカン及びそれらの製造方法
IT1296689B1 (it) * 1997-11-06 1999-07-14 Fidia Advanced Biopolymers Srl Derivati esterei dell'acido ialuronico aventi proprieta viscoelastiche e loro uso in campo biomedico-sanitario
CN100369593C (zh) 2002-06-05 2008-02-20 佛罗里达大学研究基金会有限公司 眼科给药体系
US20130136784A1 (en) 2007-10-11 2013-05-30 Robert J. Staab Methods for delivery of medication using dissolvable devices
US8361492B2 (en) 2008-04-29 2013-01-29 Ocugenics, LLC Drug delivery system and methods of use
JP5722217B2 (ja) * 2008-09-02 2015-05-20 アラーガン・ホールディングス・フランス・ソシエテ・パール・アクシオン・サンプリフィエＡｌｌｅｒｇａｎ Ｈｏｌｄｉｎｇｓ Ｆｒａｎｃｅ Ｓ．Ａ．Ｓ． ヒアルロン酸および／またはその誘導体の糸、その作製方法、ならびにその使用
US20110229551A1 (en) * 2010-03-17 2011-09-22 Notus Laboratories, Inc. Drug delivery compositions and methods using nanofiber webs
WO2013171764A2 (en) 2012-04-30 2013-11-21 Rubicon Research Private Limited Ophthalmic formulations
CZ304654B6 (cs) * 2012-11-27 2014-08-20 Contipro Biotech S.R.O. Nanomicelární kompozice na bázi C6-C18-acylovaného hyaluronanu, způsob přípravy C6-C18-acylovaného hyaluronanu, způsob přípravy nanomicelární kompozice a stabilizované nanomicelární kompozice a použití
CZ304303B6 (cs) * 2012-11-27 2014-02-19 Contipro Biotech S.R.O. Vlákna založená na hydrofobizovaném hyaluronanu, způsob jejich přípravy a použití, textilie na jejich bázi a použití
CZ304977B6 (cs) * 2013-11-21 2015-02-25 Contipro Biotech S.R.O. Nanovlákna obsahující fototvrditelný esterový derivát kyseliny hyaluronové nebo její soli, fototvrzená nanovlákna, způsob jejich syntézy, přípravek obsahující fototvrzená nanovlákna a jejich použití
EP3108874A1 (en) * 2015-06-26 2016-12-28 TRB Chemedica AG Ophthalmologic pharmaceutical composition

Also Published As

Publication number Publication date
KR20190099495A (ko) 2019-08-27
BR112019012758A2 (pt) 2019-11-26
EP3558264A1 (en) 2019-10-30
RU2019122292A3 (es) 2021-03-17
EP3558264B1 (en) 2024-07-17
RU2019122292A (ru) 2021-01-26
JOP20190137A1 (ar) 2019-06-11
AR110433A1 (es) 2019-03-27
CZ307158B6 (cs) 2018-02-07
CZ2016827A3 (cs) 2018-02-07
WO2018113805A1 (en) 2018-06-28
KR102511776B1 (ko) 2023-03-17

Similar Documents

Publication Publication Date Title
EP4279064A3 (en) Drug delivery from hydrogels
EP4374873A3 (en) Methods for treating or preventing opthalmological conditions
MA39767A (fr) Solution aqueuse ophtalmique et méthode de traitement du syndrome de l'oeil sec
MX2017010982A (es) Uso de pridopidina para mejorar la funcion cognitiva y para tratamiento de enfermedad de alzheimer.
MX2022007221A (es) Compuestos y composiciones para el tratamiento o prevencion de trastornos patologicos asociados con exceso de deposicion de fibrina y/o formacion de trombos.
BR112017002637A2 (pt) métodos para tratar ou prevenir condições oftalmológicas
WO2015171610A3 (en) Tetrahydroquinoline sulfonamide and related compounds for use as agonists of rory and the treatment of disease
AR088585A1 (es) Un medicamento para tratar la enfermedad del ojo anterior
EP4324454A3 (en) Cross-linking agents and associated methods
PH12017502155A1 (en) Formation of cyclosporin a/cyclodextrin nanoparticles
MX2019008124A (es) Metodos para el tratamiento de trastornos neurologicos.
MY199237A (en) Methods of treating ocular conditions
TN2015000356A1 (en) Bicyclic compounds
MX2017004760A (es) Formulacion esterilizada por calor que comprende quitosan y proceso para preparacion de la misma.
EA202191684A1 (ru) Средство, содержащее урсодезоксихолевую кислоту, для лечения или профилактики пресбиопии
MY193529A (en) Ophthalmologic pharmaceutical composition
MX2015012720A (es) Sales basicas de adicion de nitroxolina y usos de las mismas.
MX2019007485A (es) Preparacion oftalmologica.
WO2014117010A3 (en) Composition for ophthalmic administration
MX2019011925A (es) Conjugados y derivados de prostaglandina para tratar el glaucoma y la hipertension ocular.
WO2016191458A3 (en) Pharmaceutical compositions affecting mitochondrial redox state and methods of treatment
WO2014182696A3 (en) Bioresorbable scaffold for neurologic drug delivery
GEP20207144B (en) Ophthalmic composition comprising a synergistic combination of glycogen and hyaluronic acid or a salt thereof
MX2018005453A (es) Uso terapeutico de una solucion oftalmica acuosa esteril.
MY184873A (en) Therapeutic agent for sjogren's syndrome dry eye